• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAM8/MS2/CD156,一种在治疗炎症性和侵袭性疾病中崭露头角的药物靶点。

ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.

作者信息

Koller Garrit, Schlomann Uwe, Golfi Panagiota, Ferdous Taheera, Naus Silvia, Bartsch Jörg W

机构信息

King's College London, Department of Biochemistry, London, United Kingdom.

出版信息

Curr Pharm Des. 2009;15(20):2272-81. doi: 10.2174/138161209788682361.

DOI:10.2174/138161209788682361
PMID:19601829
Abstract

While it is highly accepted that ADAM family members with ubiquitous expression patterns, such as ADAM10 and ADAM17 have major roles in homoeostasis and pathology, ADAM8 was initially considered as an immune-specific ADAM with a cell-specific expression pattern. Therefore, ADAM8 had a "sleeping beauty" existence for many years, and has recently come back into focus as it was detected under several pathological conditions. These were found to typically involve inflammation and remodelling of the extracellular matrix, including cancers and serious respiratory diseases such as asthma. In these diseases, induced expression of ADAM8 by different stimuli results in cleavage of various substrates, including cell adhesion molecules, cytokine receptors, and ECM components. Involvement of ADAM8 in individual diseases indicates its usefulness as both a diagnostic and prognostic marker. Even more strikingly, as ADAM8 progressively emerges as a key effector in pathological processes, so does its attractiveness as a therapeutic target rather than being a mere indicator of disease and its progression. This is encouraged by analysis of ADAM8 null mice, identifying no adverse phenotype in the absence of functional ADAM8. Thus, ADAM8 potentially is an attractive drug target in a variety of diseases. In this review, the current knowledge on ADAM8 in diseases and avenues for specific inhibition based on unique biochemical features of ADAM8 will be presented.

摘要

虽然人们普遍认为具有广泛表达模式的ADAM家族成员,如ADAM10和ADAM17在体内平衡和病理学中起主要作用,但ADAM8最初被认为是一种具有细胞特异性表达模式的免疫特异性ADAM。因此,ADAM8多年来一直处于“沉睡”状态,直到最近在几种病理条件下被检测到,它才重新成为焦点。这些病理条件通常涉及炎症和细胞外基质重塑,包括癌症和严重的呼吸系统疾病,如哮喘。在这些疾病中,不同刺激诱导ADAM8表达会导致各种底物的裂解,包括细胞粘附分子、细胞因子受体和细胞外基质成分。ADAM8参与个体疾病表明它作为诊断和预后标志物的有用性。更引人注目的是,随着ADAM8逐渐成为病理过程中的关键效应因子,它作为治疗靶点的吸引力也在增加,而不仅仅是疾病及其进展的指标。对ADAM8基因敲除小鼠的分析支持了这一点,该分析表明在缺乏功能性ADAM8的情况下没有不良表型。因此,ADAM8在多种疾病中可能是一个有吸引力的药物靶点。在这篇综述中,将介绍目前关于ADAM8在疾病中的知识以及基于ADAM8独特生化特性的特异性抑制途径。

相似文献

1
ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.ADAM8/MS2/CD156,一种在治疗炎症性和侵袭性疾病中崭露头角的药物靶点。
Curr Pharm Des. 2009;15(20):2272-81. doi: 10.2174/138161209788682361.
2
ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.ADAM8 在侵袭性癌症中的作用:与肿瘤进展、转移和化疗耐药的关系。
Clin Sci (Lond). 2019 Jan 11;133(1):83-99. doi: 10.1042/CS20180906. Print 2019 Jan 15.
3
ADAM8 in allergy.ADAM8与过敏反应
Inflamm Allergy Drug Targets. 2008 Jun;7(2):108-12. doi: 10.2174/187152808785107598.
4
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.鉴定金属蛋白酶-解整合素ADAM8介导的胞外域脱落的候选底物。
Biol Chem. 2006 Mar;387(3):337-46. doi: 10.1515/BC.2006.045.
5
Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays.人 ADAM8 的金属蛋白酶抑制剂谱在体外和基于细胞的测定中的分析。
Biol Chem. 2019 May 27;400(6):801-810. doi: 10.1515/hsz-2018-0396.
6
A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.一种新型肽类ADAM8抑制剂可减轻小鼠哮喘模型的支气管高反应性和Th2细胞因子介导的炎症。
Sci Rep. 2016 Jul 26;6:30451. doi: 10.1038/srep30451.
7
A jack of all trades - ADAM8 as a signaling hub in inflammation and cancer.万金油 - ADAM8 在炎症和癌症中的信号枢纽作用。
FEBS J. 2024 Sep;291(18):3989-4008. doi: 10.1111/febs.17034. Epub 2023 Dec 22.
8
The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma.金属蛋白酶-解整合素 ADAM8 对于实验性哮喘的发展是必需的。
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1318-28. doi: 10.1164/rccm.200909-1396OC. Epub 2010 Mar 1.
9
ADAM10 as a therapeutic target for cancer and inflammation.ADAM10作为癌症和炎症的治疗靶点。
Curr Pharm Des. 2009;15(20):2288-99. doi: 10.2174/138161209788682442.
10
Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.去整合素金属蛋白酶8(ADAM8)在实验性哮喘中的表达及调控
Am J Respir Cell Mol Biol. 2004 Sep;31(3):257-65. doi: 10.1165/rcmb.2004-0026OC. Epub 2004 Apr 15.

引用本文的文献

1
Copy Number Variation in Asthma: An Integrative Review.哮喘中的拷贝数变异:一项综合综述。
Clin Rev Allergy Immunol. 2025 Jan 4;68(1):4. doi: 10.1007/s12016-024-09015-0.
2
Blockade of the ADAM8-Fra-1 complex attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis after spinal cord injury.阻断 ADAM8-Fra-1 复合物通过抑制脊髓损伤后的 Map3k4/MAPKs 轴减轻神经炎症。
Cell Mol Biol Lett. 2024 May 16;29(1):75. doi: 10.1186/s11658-024-00589-3.
3
ADAM8 silencing suppresses the migration and invasion of fibroblast-like synoviocytes via FSCN1/MAPK cascade in osteoarthritis.
ADAM8 沉默通过 FSCN1/MAPK 级联抑制骨关节炎成纤维样滑膜细胞的迁移和侵袭。
Arthritis Res Ther. 2024 Jan 13;26(1):20. doi: 10.1186/s13075-023-03238-w.
4
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients.ADAM8在乳腺癌中广泛表达,并且预测激素受体阳性、HER-2阴性患者的预后不良。
Cancer Cell Int. 2023 Aug 11;23(1):165. doi: 10.1186/s12935-023-03024-3.
5
The versatile roles of ADAM8 in cancer cell migration, mechanics, and extracellular matrix remodeling.ADAM8在癌细胞迁移、力学及细胞外基质重塑中的多种作用。
Front Cell Dev Biol. 2023 Feb 23;11:1130823. doi: 10.3389/fcell.2023.1130823. eCollection 2023.
6
Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.脑转移乳腺癌:关注相关基因与信号通路、血脑屏障及治疗策略。
Clin Transl Oncol. 2023 May;25(5):1218-1241. doi: 10.1007/s12094-022-03050-z. Epub 2023 Mar 10.
7
The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma.胶质母细胞瘤肿瘤微环境作为治疗反应的调节因子:ADAM8通过HB-EGF/EGFR介导的CCL2表达导致肿瘤相关巨噬细胞的肿瘤浸润并克服胶质母细胞瘤中替莫唑胺的化学增敏作用。
Cancers (Basel). 2022 Oct 7;14(19):4910. doi: 10.3390/cancers14194910.
8
Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors.二聚体芳基磺酰胺作为强效ADAM8抑制剂的发现。
ACS Med Chem Lett. 2021 Oct 8;12(11):1787-1793. doi: 10.1021/acsmedchemlett.1c00411. eCollection 2021 Nov 11.
9
Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.三种潜在的肿瘤标志物通过调节炎症反应促进结直肠癌的转移和复发:ADAM8、LYN 和 S100A9。
Comput Math Methods Med. 2022 Jan 22;2022:3118046. doi: 10.1155/2022/3118046. eCollection 2022.
10
Leukocyte Membrane Enzymes Play the Cell Adhesion Game.白细胞膜酶在细胞黏附中扮演重要角色。
Front Immunol. 2021 Nov 23;12:742292. doi: 10.3389/fimmu.2021.742292. eCollection 2021.